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Challenges	 intrinsic	 to	 the	 accurate	 diagnosis	 of	 endometriosis	 contribute	 to	 an	
extended	 delay	 between	 the	 onset	 of	 symptoms	 and	 clinical	 confirmation.	
Intraoperative	visualization,	 preferably	with	histologic	 verification,	 is	 considered	by	
many	professional	organizations	 to	be	 the	gold	standard	by	which	endometriosis	 is	
diagnosed.	Clinical	diagnosis	of	symptomatic	endometriosis	via	patient	history,	physi-










conveys	minimal	 risk	 of	 under-	 or	 over-	diagnosis,	 lessens	 the	 time	 from	 symptom	
development	 to	 diagnosis,	 and	 guides	 the	 appropriate	 use	 of	medical	 and	 surgical	
management	strategies.





imately	 6%–10%	 of	 reproductive-	aged	 women.1	 Pain,	 a	 frequent	
symptom	of	endometriosis	that	manifests	as	dysmenorrhea,	chronic	
pelvic	 pain,	 dyspareunia,	 and/or	 dyschezia,	 can	 be	 debilitating.	
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productivity,	with	 substantial	 economic	 consequences.2,3	 The	 other	





The	 profound	 influence	 of	 untreated	 endometriosis	 on	 many	
aspects	of	women’s	 lives	underscores	the	need	for	timely	diagno-
sis	and	 initiation	of	 treatment.	Nonetheless,	diagnostic	challenges	
coupled	with	 the	 requirement	 for	 surgical	 intervention	 to	make	 a	
diagnosis	often	result	in	considerable	delay	to	clinical	management	
of	 affected	 individuals.	 Studies	 that	 have	 evaluated	 the	 timing	 of	
diagnosis	in	various	parts	of	the	world	have	consistently	reported	a	
mean	or	median	interval	of	at	least	7	years	from	the	time	a	patient	
first	 experiences	 symptoms	 of	 endometriosis	 until	 she	 receives	 a	
confirmed	 diagnosis.2,4,5	 In	 the	 interim,	 many	women	with	 endo-




The	best	methods	 to	 diagnose	 endometriosis	 and	 to	 determine	
the	 extent	 and	 pathologic	 severity	 of	 this	 disease	 are	 subject	 to	
debate.1	Visualization—typically	by	laparoscopy	with	histologic	confir-
mation—is	generally	considered	to	be	the	gold	standard	(Table	1).1,6–9 





of	 Obstetricians	 and	 Gynecologists,1	 the	 Society	 of	 Obstetricians	
and	 Gynaecologists	 of	 Canada,7	 the	 European	 Society	 of	 Human	
Reproduction	and	Embryology8	 (also	endorsed	by	the	Royal	College	
of	Obstetricians	 and	Gynaecologists),	 and	 the	World	 Endometriosis	
Society	(WES).9	These	organizations	advocate	for	empiric	treatment	
before	 laparoscopy	 in	 selected	patients	 (Table	1).1,7–9	The	American	
Society	 for	 Reproductive	 Medicine	 (ASRM)	 guidelines	 state	 that	
laparoscopy	 before	 empiric	 treatment	 is	 the	 “preferred	 approach,	
although	 further	 studies	are	warranted”	 (Table	1).6	These	guidelines	
are	 predicated	 on	 the	 assumption	 that	 isolated	 clinical	 diagnosis	 is	
of	 limited	 accuracy.	 Nonetheless,	 as	 understanding	 of	 endometri-
osis	 increases	 and	 improved	 noninvasive	methods	 for	 its	 detection	
are	 developed,	 reevaluation	 of	 clinical	 diagnosis	 as	 a	viable,	 practi-















by	 the	 presence	 of	 lesions,	which	 vary	 considerably	 in	 appearance,	
size,	and	 location,	and	are	histologically	confirmed	by	the	detection	
of	endometrial	glands,	endometrial	stroma,	and/or	hemosiderin-	laden	
macrophages.	 However,	 an	 internationally	 accepted	 definition	 pro-
posed	 in	 2017	 describes	 endometriosis	 as	 “a	 disease	 characterized	
by	the	presence	of	endometrium-	like	epithelium	and	stroma	outside	
the	endometrium	and	myometrium.	Intrapelvic	endometriosis	can	be	
located	 superficially	 on	 the	 peritoneum	 (peritoneal	 endometriosis),	










Ambiguity	 is	 also	 found	 in	 the	 staging	 of	 endometriosis.	 A	
broadly	applicable	and	prognostically	relevant	classification	system	










to	derive	 this	 classification	 system	had	been	designed	 to	predict	
the	efficacy	of	conservative	surgical	treatment	to	improve	fertility	
and	did	not	include	pain	as	an	outcome	variable.15	Indeed,	women	
with	 disease	 categorized	 as	 stage	 I	 or	 II	 can	 experience	 consid-
erable	 pain,	 infertility,	 or	 other	 endometriosis-	related	 symptoms,	





the	 rASRM	classification	has	 the	advantages	of	being	 simple	 to	use	
and	easy	for	patients	to	understand,	the	caveats	discussed	above,	as	
well	 as	 its	 lack	of	utility	 in	 the	classification	of	deep	endometriosis,	
make	it	less	than	ideal.	A	newer	concept	is	to	categorize	endometriosis	
by	 its	 presentation:	 superficial,	 ovarian	 endometrioma,	 or	 deep	 dis-
ease.	Associations	have	been	made	between	symptom	presentation	
and	 endometriosis	 stratified	 into	 these	 three	 categories	 (discussed	
below	in	Section	3).17,18









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3  | CLINICAL DIAGNOSIS  
OF ENDOMETRIOSIS
Clinical	 presentations	 of	 endometriosis	 are	 highly	 diverse;	 none	 of	
the	 presenting	 signs	 or	 symptoms	 are	 pathognomonic	 for	 this	 dis-
ease.	 Because	 of	 the	 overlap	 in	 symptoms	with	 other	 gynecologic	
conditions	 (e.g.,	 primary	 dysmenorrhea,	 adenomyosis,	 pelvic	 adhe-
sions,	ovarian	cysts,	 pelvic	 inflammatory	disease)7	 and	chronic	pain	
syndromes	 (e.g.,	 irritable	 bowel,	 interstitial	 cystitis/painful	 bladder,	
fibromyalgia,	musculoskeletal	disorders),6	differential	diagnosis	 is	an	
important	 facet	 of	 identifying	 endometriosis.	 By	 way	 of	 example,	
gynecologic	 conditions	 such	 as	 primary	 dysmenorrhea,	 adenomyo-
sis,	pelvic	adhesions,	ovarian	cysts,	and	pelvic	 inflammatory	disease	




be	 informative	 for	 ruling	out	other	causes	of	pelvic	pain.	 Individual	
symptoms	may	 be	 informative	 in	 terms	 of	 assessing	 the	 likelihood	
that	 a	 patient	 has	 endometriosis	 but	 cannot,	 in	 and	of	 themselves,	
rule	endometriosis	in	or	out.
3.1 | Discriminatory value of pelvic pain
Pelvic	pain	is	a	common	occurrence	among	the	general	population.20 
Although	 pain	 is	 a	 cardinal	 symptom	 of	 endometriosis,	 discerning	






metriosis.14,21–30	 Overall,	 dysmenorrhea	 is	 the	 most	 frequent	 pain	
symptom,	reported	by	the	majority	of	women	who	have	proven	endo-
metriosis.	Chronic	pelvic	pain	and/or	chronic	nonmenstrual	pelvic	pain	




can	 help	 to	 distinguish	 between	 primary	 and	 secondary	 dysmenor-
rhea,	the	latter	being	a	catch-	all	category	for	pain	caused	by	disorders	










Attempts	 to	 detect	 correlations	between	 the	 severity	 of	 disease	
(as	defined	by	the	volume,	location,	or	type	of	endometriotic	lesions)	
and	 the	 prevalence	 or	 severity	 of	 pain	 have	 produced	 disparate	
results.21,26,27,29	Although	a	study	by	Ashrafi	et	al.21	found	an	increased	
proportion	of	patients	who	reported	dysmenorrhea,	pelvic	pain,	and/
or	 dyspareunia	 among	 those	with	 stage	 III–IV	 versus	 stage	 I–II	 dis-
ease,	other	investigators	have	not	observed	such	a	correlation.14,26,27 
However,	it	is	important	to	note	that	the	population	studied	by	Ashrafi	
et	al.21	 comprised	 infertile	 women,	 who	 could	 be	 a	 physiologically	
different	 group	 than	 women	 with	 endometriosis	 who	 have	 never	
experienced	 infertility.	As	mentioned	above	 in	Section	2,	 the	rASRM	
classification	of	endometriosis	staging	was	not	designed	to	reflect	the	
degree	of	pain	that	a	patient	might	be	experiencing.
The	data	are	also	 inconsistent	 regarding	a	 link	between	 location	

















of	endometriosis	 in	 asymptomatic	women	 is	not	 known.	Reports	of	
endometriosis	observed	at	 the	time	of	 laparoscopic	 tubal	 ligation	 in	
asymptomatic	women	are	limited,	and	what	reports	are	available	likely	
underestimate	 disease	 burden	 because	 the	 thoroughness	 of	 perito-
neal	surface	examination	is	typically	much	greater	in	symptomatic	ver-
sus	asymptomatic	women.
3.2 | Infertility as an indicator of endometriosis
Infertility	is	considerably	more	common	among	women	with	endome-
triosis	than	among	individuals	without	this	condition.	In	a	UK	case–
control	 study,	 women	 diagnosed	 with	 endometriosis	 were	 greater	
than	six	times	more	 likely	 to	have	a	history	of	 infertility	 than	were	
women	 without	 endometriosis.24	 Given	 this	 association,	 endome-
triosis	 should	be	 considered	 as	 a	 possible	 cause	of,	 or	 comorbidity	
among,	women	with	 infertility,	 particularly	 those	who	demonstrate	
     |  5Taylor ET al.
other	 symptoms	 consistent	 with	 endometriosis.	 Pain,	 menstrual	




3.3 | Other symptomatic indicators of endometriosis
Studies	 evaluating	 risk	 factors	 or	 characteristics	 associated	 with	
endometriosis	have	reported	linkage	with	longer	duration	of	men-
ses,	 shorter	 menstrual	 cycle	 length,	 increased	 menstrual	 volume,	
irregular	 menstrual	 periods,	 post-	coital	 bleeding,	 and	 dysche-
zia,21,24,25,32	although	 the	findings	are	not	consistent.	Whereas	no	
single	 characteristic	 may	 reach	 significance	 as	 a	 prognostic	 fac-
tor	on	a	population	 level,	a	constellation	of	endometriosis-	related	
symptoms	 can	 be	 a	 strong	 indicator	 of	 disease.	 Indeed,	 Ballard	
et	al.24	 found	 that	 the	 likelihood	 of	 endometriosis	 increased	with	
the	 number	 of	 symptoms	 present,	with	 elevations	 in	 relative	 risk	
ranging	from	five-	fold	for	one	symptom	to	85-	fold	when	seven	or	
more	symptoms	were	present.
3.4 | Accuracy of physical examination as a 
diagnostic tool
Multiple	 studies	 have	 sought	 to	 quantify	 the	 ability	 of	 a	 physical	
examination	to	detect	endometriosis	by	gauging	its	accuracy	relative	
to	surgical	diagnosis	(Table	3).28,33–37	Patient	selection	and	examina-
tion	 methods	 differ	 among	 individual	 studies,	 which	 confound	 the	
overall	 estimation	 of	 accuracy.	 These	 limitations	 notwithstanding,	
the	specificity	(percentage	of	all	patients	without	surgically	confirmed	
endometriosis	who	have	a	negative	clinical	diagnosis),	positive	predic-
tive	value	 (PPV;	percentage	of	 all	 patients	with	 clinically	 diagnosed	
endometriosis	 that	 is	 surgically	 verified),	 and	 negative	 predictive	
value	 (NPV;	 percentage	 of	 all	 patients	 without	 clinically	 diagnosed	
TABLE  2 Common	pain	symptoms	among	women	with	endometriosis.a
Study (no. of patients) Population
Patients
Dysmenorrhea CPPb Dyspareunia
Ashrafi	et	al.	201621	(n=673) Infertile	women	with	laparoscopically	diagnosed	endometriosis 54–81c 31–52c 29–55c




Schliep	et	al.	201514	(n=326) Women	with	laparoscopically	diagnosed	endometriosis 38–91 44 14–55
Women	with	a	laparoscopically	normal	pelvis 38–79 30 9–32
Bellelis	et	al.	201023	(n=892) Women	with	histologically	confirmed	endometriosis 28d 57 55
Ballard	et	al.	200824	(n=5540) Women	with	a	diagnosis	of	endometriosis 25e 16e 9e
Matched	control	individuals 3e 2e 1e
Flores	et	al.	200825	(n=1285) Women	with	self-	reported	endometriosis 83 80 52















Porpora	et	al.	1999	29	(n=90) Consecutive	women	with	histologically	confirmed	endometriosis 66 f 49 f 38	f
Forman	et	al.	199330	(n=99) Infertile	women	with	laparoscopically	diagnosed	endometriosis 53 20 23


















by	 their	 location.	The	 lower	values	 for	 sensitivity	 (18%–88%)	when	
compared	with	specificity	(46%–100%)	or	PPV	(40%–100%)	suggest	
that	 false-	negative	 physical	 examination	 findings	 occur	 more	 fre-
quently	than	do	false-	positive	findings.
4  | IMAGING STUDIES AS AN ADJUNCT TO 
CLINICAL DIAGNOSIS
The	data	described	above	in	Section	3.4	and	presented	in	Table	3	







Imaging	 methods	 such	 as	 ultrasonography	 have	 inherent	 value	 for	
their	ability	to	identify	causes	of	abdominal	pain	and	menstrual	symp-
toms	other	than	endometriosis	(e.g.	adenomyosis).	 In	the	context	of	















Ovary 41 99 92 87
Rectum	and/or	sigmoid 39 97 86 84
USL 50 80 43 84
Pouch	of	Douglas 76 92 64 95
Vagina 73 98 80 97
RVS 78 98 78 98






Right/left	ovary 38/23 99/99 90/75 92/90
Right/left	USL 52/74 97/89 67/65 94/93
Pouch	of	Douglas 70 98 84 95
Vagina 64 100 100 96
RVS 88 99 78 99
Bladder 25 100 100 98








USL 74 78 97 24
Vagina 50 87 65 78
RVS 18 96 40 90





Rectosigmoid 72 54 63 64






















A	 strong	 correlation	 has	 been	 observed	 between	 TVUS	 mark-
ers	 and	 laparoscopic	findings.	Among	120	consecutive	women	with	
chronic	 pelvic	 pain	 evaluated	 by	 Okaro	 et	al.,38	 “hard	 markers”	 on	







treatment,	 as	 61	 of	 75	 (81%)	women	 evaluated	 by	TVUS	 had	 their	
need	for	treatment	confirmed	laparoscopically.
TVUS	 is	generally	considered	 the	first-	line	 imaging	approach	 for	














raphy	 findings	 are	 equivocal1,7	 and	 in	 carefully	 selected,	 high-	risk	
patients	 (e.g.,	 those	 with	 extensive	 pelvic	 adhesions	 of	 suspected	
ureteral	involvement).41	Nonetheless,	this	method	is	helpful	for	cases	
where	 ultrasonographic	 findings	 are	 equivocal1,7	 or	 for	 use	 among	
carefully	selected	high-	risk	patients	such	as	those	with	extensive	pel-
vic	adhesions	or	suspected	ureteral	involvement.41	One	advantage	of	









(Table	1).	 The	 recommendations	 provided	 reflect	 the	 available	 evi-
dence	at	 the	time	when	each	document	was	developed,	 the	expert	
opinions	of	the	writing	committee	members,	and	the	questions	that	
these	committees	were	 seeking	 to	answer.	Hence,	 such	differences	
are	not	unexpected.	As	the	evidence	base	for	 imaging	modalities	 in	
the	diagnosis	of	endometriosis	grows,	 it	 is	 likely	 that	 increased	uni-
formity	and	strength	of	imaging	recommendations	will	emerge.
Estimates	of	the	accuracy	of	physical	examination,	with	or	without	












toms,	 clinical	 factors,	 and	 patient	 characteristics,	 Nnoaham	 et	al.32 





5  | SURGICAL DIAGNOSIS  
OF ENDOMETRIOSIS









to	 their	 heterogeneous	 visual	 appearance	 and	 the	 fact	 that	 non-	
pigmented	peritoneal	 lesions	often	represent	highly	active	endome-
triotic	implants.47	Visual	identification	is	compromised	by	the	myriad	
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understanding	of	the	natural	history	of	superficial	peritoneal	endome-
triosis	lesions.	As	shown	in	Table	4,	a	survey	of	studies	that	evaluated	
the	 accuracy	 of	 laparoscopic	 identification	 reveals	 that	 as	 many	 as	
67%	of	 lesions	considered	 to	be	endometriosis	on	visual	 inspection	










for	 these	 locations	were	 39%–56%,	 suggesting	 a	 high	 degree	 of	
false-	negative	 results;	 these	 cases	 tended	 to	 be	 atypical	 lesions	





this	high	confirmation	 rate	 is	achieved	 in	clinical	practice	 remains	
to	be	determined.
Comparisons	 among	 studies	 also	 reveal	 considerable	 hetero-
geneity	 in	the	sensitivity,	specificity,	PPV,	and	NPV	of	 laparoscopic	
diagnosis	of	endometriosis	 (Table	4),	which	may	be	due,	 at	 least	 in	
part,	to	interobserver	variability.	This	phenomenon	can	compromise	
accurate	 diagnosis	 of	 endometriosis	 by	 laparoscopy.44	 Differences	
in	lesion	interpretation	and	staging	can	occur	among	laparoscopists	
and/or	pathologists	evaluating	biopsy	results.	 Interestingly,	a	study	
that	 evaluated	 inter-	rater	 agreement	 on	 endometriosis	 diagnosis	
and	staging	found	that	surgeons	and	expert	reviewers	demonstrated	
TABLE  4 Accuracy	of	laparoscopic	visualization	for	diagnosis	of	endometriosis.a,b
Study (no. of patients) Population Stage Sensitivity Specificity PPV NPV
Fernando	et	al.	201344	(n=431) Women	who	underwent	laparoscopic	biopsy	for	
suspected	endometriosis
All NA NA 75 NA
I NA NA 50 NA
II NA NA 80 NA
III NA NA 78 NA
IV NA NA 79 NA
Stegmann	et	al.	200845	(n=133) Women	who	underwent	laparoscopic	biopsy	for	
chronic	pelvic	pain
All 98 21 64 88
Kazanegra	et	al.	200846	(n=104) Women	who	underwent	laparoscopic	biopsy	for	
suspected	endometriosis
All NA NA 87 NA
I NA NA 76 NA
II NA NA 90 NA
III NA NA 100 NA
IV NA NA 91 NA
El	Bishry	et	al.	200848	(n=48) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All NA NA 75 NA
I NA NA 33 NA
II NA NA 71 NA
III NA NA 92 NA
IV NA NA 73 NA
Almeida	Filho	et	al.	200849	(n=976) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain	and/or	infertility
All 98 79 72 98
Albee	et	al.	200850	(n=512) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All 62–100b 40–83c 71–94c 26–100c
Stratton	et	al.	200351	(n=48) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All NA NA 86 NA
I NA NA 62 NA
II NA NA 100 NA
III NA NA 100 NA
IV NA NA 86 NA
Walter	et	al.	200152	(n=44) Women	who	underwent	laparoscopic	biopsy	for	
chronic	pelvic	pain
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high	levels	of	agreement	when	viewing	digital	images	of	laparoscopic	
findings	or	operative	reports.53	However,	agreement	decreased	con-
siderably	 after	 viewing	 histologic	 findings.	 These	 results	 highlight	
potential	 differences	 in	 interpretation	 among	 laparoscopists	 and	
pathologists	that	are	further	obscured	by	ambiguities	and	differences	
in	the	available	staging	systems.




also	occur.	Major	 or	minor	 adverse	 events	 arising	 from	 laparoscopy	




of	 non-	endometriosis	 pathology	when	 determining	 the	 appropriate	
course	of	management	for	an	individual	patient.
6  | RECOMMENDATIONS FOR  
RESHAPING THE DIAGNOSIS  
OF ENDOMETRIOSIS











by	 improving	 and	 quantifying	 the	 value	 of	 nonsurgical	 diagnosis	
of	 symptomatic	 endometriosis.	 Our	 approach	 to	 the	 question	 of	
surgical	 versus	 clinical	 diagnosis	 of	 symptomatic	 endometriosis,	
though	informative	and	based	on	clinical	evidence,	should	be	con-
sidered	hypothesis-	generating.	We	see	the	next	step	in	reconciling	
this	 query	 to	 be	 a	 collaboration	 among	 professional	 societies	 to	
analyze	 the	data	 critically	 and	 introduce	quantitative	 approaches	
to	 diagnosis.	 This	 undertaking	 would	 involve	 multiple	 areas	 of	
	investigation	(Box	1).
At	 the	 most	 rudimentary	 level,	 development	 of	 an	 algorithm	
based	 on	 clinical	 evaluations	 that	 could	 identify	 patients	 with	 the	
greatest	 likelihood	of	endometriosis	who	are,	 therefore,	 candidates	





6.2 | Long- term needs and opportunities
Increased	 understanding	 of	 the	 natural	 history	 of	 endometriosis	
as	 it	 relates	 to	 symptom	 development	 and	 presentation	 (e.g.	 pain,	
menstrual	 anomalies,	 gastrointestinal	 symptoms,	 fatigue,	 bloating,	
and	paresthesia)	would	help	clinicians	to	differentiate	endometriosis	
from	other	conditions	 that	share	symptomology.	This	 type	of	 infor-
mation	 is	best	gleaned	through	clinical	studies	that	examine	patient	
experiences	with	 symptoms	and	how	 they	vary	with	time,	age,	 and	
menstrual	 cycle.	 Comparative	 data,	 collected	 from	 patient	 diaries,	
could	be	gathered	 from	women	with	 and	without	 endometriosis	 to	
determine	how	the	type,	frequency,	and	severity	of	symptoms	differ	
between	these	two	groups,	with	further	analysis	by	demographic	and	
B O X  1  Improving	Endometriosis	Diagnosis:	Topics	for	
Future	Research	and	Development

















fertility,	 relief	 of	 chronic	pain,	 reduced	 risk	of	 clear	 cell	 or	
endometrioid	 ovarian	 carcinoma,	 and	 fewer	 cases	 of	 pre-
eclampsia	 and	 preterm	 delivery).55–58	 Nonetheless,	 expert	
opinion	and	clinical	experience	support	the	plausibility	that	
early	diagnosis	will	reduce	long-term	morbidity.59	The	argu-
ment	 for	 early	 diagnosis	 is	 further	 strengthened	 by	 the	
observation	 that	 advanced-stage	 disease	 is	more	 common	
among	young	women	than	has	been	typically	appreciated.60 
To	assess	the	question	of	the	clinical	value	of	early	diagnosis	
in	 the	 prevention	 of	 endometriosis-related	 sequelae,	 data	
mining	can	be	applied	to	existing	repositories,	such	as	medi-





erences,	 cost-effectiveness,	 and	ease	of	 implementation	 in	
clinical	practice.






then	 be	 developed	 from	 these	 data	 to	 illustrate	 the	 differences	 in	
symptomology	 among	 women	with	 endometriosis,	 women	without	
endometriosis,	and	women	with	other	gynecologic	conditions.
Understanding	 disease	 pathogenesis	 is	 also	 a	 first	 step	 to	 bio-
marker	development.	To	date,	no	single	biomarker	or	combination	of	
biomarkers	 (e.g.	 endometrial,	 blood-	based,	 or	 urinary)	 has	 emerged	
as	 the	 standard	 for	 diagnosis	 of	 endometriosis.62–65	 The	 lack	 of	 a	
definitive	 biomarker	 is	 not	 an	 indictment	 of	 those	 that	 have	 been	





several	 promising	 biomarkers	 for	 endometriosis.66–68	 Development	
of	 biomarkers	 in	 the	 context	 of	 endometriosis	 would	 be	 bolstered	
by	well-	designed	studies	that	include	biomarkers	in	conjunction	with	
other	clinical	diagnostic	measures.	The	World	Endometriosis	Research	
Foundation	 Endometriosis	 Phenome	 and	Biobanking	Harmonisation	





able	opportunity	 to	 reduce	 the	time	 to	diagnosis	 for	 a	disease	 that	
creates	a	major	quality-	of-	life	burden	for	many	affected	 individuals.	
Second,	a	clinical	diagnosis	could	have	distinct	value	because	it	is	non-






















empiric	 therapy	 is	 appropriate	 for	 patients	 whose	 symptoms	 and	
clinical	evaluation	are	consistent	with	endometriosis	(e.g.	women	with	
cyclic	progressive	pelvic	pain	not	attributable	to	other	conditions).
The	 potential	 for	 clinical	 diagnosis	 of	 symptomatic	 endometrio-
sis	does	not	negate	 the	value	of	 laparoscopy	nor	does	 it	mean	 that	
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